A new trial at Beth Israel Deaconess Medical Center is aiming to disrupt COVID-19’s attack early in its course by treating patients immediately after symptoms appear with a widely used antiviral drug that, if it works, could be rapidly repurposed to fight the coronavirus.
Oct. 29, 2020 • ~4 min
covid-19 coronavirus harvard-medical-school health-medicine alvin-powell beth-israel-deaconess-medical-center antiviral nathan-shapiro treat-now
BIDMC-led research team reports vaccine protection against severe COVID-19-related pneumonia and death.
Sept. 3, 2020 • ~4 min
covid-19 coronavirus health-medicine beth-israel-deaconess-medical-center vaccine dan-barouch
A single-shot COVID-19 vaccine is being developed by scientists led by a Beth Israel Deaconess Medical Center immunologist.
July 30, 2020 • ~5 min
covid-19 harvard-medical-school mit health-medicine beth-israel-deaconess-medical-center sars-cov-2 and-harvard adenovirus-serotype-26 johnson-johnson ragon-institute-of-massachusetts-general-hospital
A Beth Israel Deaconess Medical Center study showed dramatic drops in hospital visits for heart attacks and stroke, which likely led to uncounted deaths at home during the COVID crisis. Perhaps more troubling is the potential for long-term damage to decades’ work to catch conditions in their earliest, most treatable stages.
May 22, 2020 • ~12 min
stroke cancer covid-19 coronavirus harvard-medical-school health-medicine alvin-powell heart-attack beth-israel-deaconess-medical-center emergency-room dhruv-kazi
An outpouring of volunteers and equipment from the Harvard medical community have helped a Harvard hospital testing lab meet COVID’s challenge.
May 11, 2020 • ~9 min
covid-19 health-medicine alvin-powell beth-israel-deaconess-medical-center sars-cov-2 jeffrey-saffitz testing annie-cheng erin-duffy james-kirby jihoon-lim laboratory-technician molecular-diagnostics-lab pathology volunteer
Team at Harvard plans to launch a clinical trial for a potential COVID-19 vaccine in the fall.
April 13, 2020 • ~10 min
mit health-medicine boston-childrens-hospital david-mooney wyss-institute-for-biologically-inspired-engineering beth-israel-deaconess-medical-center dan-barouch precision-vaccines-program stephen-elledge massachusetts-consortium-on-pathogen-readiness ragon-institute-of-mgh and-harvard david-dowling gerhard-wagner mahmoud-nasr ofer-levy
Aldatu Biosciences, a company born in Harvard’s labs and nurtured in its entrepreneurial ecosystem, helps the region ramp up COVID-19 testing.
March 31, 2020 • ~9 min
covid-19 coronavirus harvard-medical-school health-medicine alvin-powell office-of-technology-development max-essex beth-israel-deaconess-medical-center aldatu-biosciences christopher-rowley david-raiser grant-zimmerman i-lab iain-macleod isaac-kohlberg jeffrey-saffitz pagliuca-harvard-life-lab pandaa
Boston-area researchers are collaborating as part of an international partnership working on a response to the new coronavirus.
Feb. 25, 2020 • ~9 min
covid-19 coronavirus china basic-research harvard-medical-school health-medicine alvin-powell harvard-th-chan-school-of-public-health massachusetts-general-hospital george-daley beth-israel-deaconess-medical-center bruce-walker virus vaccine dan-barouch david-knipe guangzhou-institute-of-respiratory-health mark-namchuk therapeutics
With legal marijuana easier to find, a Harvard professor addresses myths and progress finding answers about pot’s health impacts.
Feb. 24, 2020 • ~17 min
harvard-medical-school health-medicine alvin-powell beth-israel-deaconess-medical-center cannabinoids cannabis kevin-hill legalization marijuana schedule-1
A national analysis revealed an alarming decline in primary care use, which is associated with better health outcomes than episodic, inconsistent care. The decline was most pronounced among younger Americans and those without complex medical conditions.
Dec. 16, 2019 • ~3 min
basic-research harvard-medical-school health-medicine brigham-and-womens-hospital jake-miller beth-israel-deaconess-medical-center bruce-landon david-levine primary-care